Avid Bioservices mailed proxy materials for a stockholder vote on its acquisition by GHO Capital and Ampersand, scheduled for January 30, 2025.Quiver AI SummaryAvid Bioservices, Inc. has announced the...
Avid Bioservices: Fiscal Q2 Earnings Snapshot
Avid Bioservices reports Q2 revenue growth of 32% but higher costs result in increased net loss; acquisition planned with GHO and Ampersand.Quiver AI SummaryAvid Bioservices, Inc., a biologics contract...
Avid Bioservices: Fiscal Q1 Earnings Snapshot
Monday U.S. Featured Earnings Avid Bioservices, Inc. (NASDAQ: CDMO) (Q4) EPS of two ...
Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains.
The specialty healthcare services provider had a fiscal fourth quarter to forget.